NeuroPace(NPCE) - 2024 Q3 - Quarterly Results

NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance Grew revenue 28% year-over-year to $21.1 million in Q3 2024 Increased full-year 2024 revenue guidance to $78 million to $80 million Demonstrated continued operating discipline through further decrease in cash burn Management scheduled to host a conference call today at 4:30 p.m. ET Mountain View, Calif. – November 12, 2024 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of ...